Keyphrases
Adverse Cardiac Events
42%
All-cause Mortality
14%
Complete Revascularization
100%
Confidence Interval
14%
Cost-effectiveness
14%
Cost-effectiveness Acceptability Curves
28%
Economic Evaluation
100%
EQ-5D-3L
14%
Heart Failure
14%
Heart Ischemia
14%
Hospital Costs
28%
Hospital Stay
14%
Incremental Cost
14%
Incremental Cost-effectiveness Ratio
14%
Incremental Effect
14%
Index Admission
42%
Infarct-related Artery
57%
Intervention Procedures
14%
Life Cost
14%
Mean Reduction
14%
Multicenter Randomized Trial
14%
Multiple Imputation
14%
Overall Cost
14%
Primary Percutaneous Coronary Intervention
100%
Quality-adjusted Life Years
57%
Readmission
14%
Recurrent Myocardial Infarction
14%
Result-oriented
14%
Revascularization
14%
Small Vessel Disease
100%
ST-elevation Myocardial Infarction (STEMI)
14%
Willingness to Pay
14%
Medicine and Dentistry
Artery
50%
Cause of Death
12%
Congestive Heart Failure
12%
Cost-Effectiveness Analysis
50%
Disease
100%
Health Care Cost
62%
Heart Muscle Ischemia
12%
Hospital Cost
25%
Infarction
50%
Major Adverse Cardiac Event
37%
Myocardial Infarction
12%
Primary Percutaneous Coronary Intervention
100%
Quality Adjusted Life Year
50%
Revascularization
100%
ST Segment Elevation Myocardial Infarction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cause of Death
25%
Congestive Heart Failure
25%
Disease
100%
Heart Infarction
25%
Heart Muscle Ischemia
25%
Infarction
100%
Major Adverse Cardiac Event
75%
ST Segment Elevation Myocardial Infarction
25%